Posted by Mishal on January 1, 2008, at 4:23:03
In reply to Down with Benzos? ARCALION can feed...., posted by Mishal on January 1, 2008, at 4:20:11
Arcalion (Sulbutiamine) is an antiasthenic drug synthesized and developed by SERVIER, France
Arcalion is a symptomatic treatment of functional asthenia. It is intended for the various manifestations of asthenia such as fatigue, memory difficulties, intellectual tiredness and convalescence from illness and infections.
Arcalion acts on the nervous structures responsible for physical activity, attention, and wakefulness.
Arcalion helps the tired organs to recover its mental and physical capacities.
Arcalion is intended for the various manifestations of asthenia such as fatigue, memory difficulties, intellectual tiredness and convalescence from illness and infections.
Contraindications: History of hypersensitivity to this drug.
Side effects: In elderly patients, rare report of mild agitation has been observed. There is a possibility of a skin allergy. In these rare cases, it is enough to stop the treatment and inform your physician.
Dosage: The usual dosage of Arcalion in adult is 2 tablets per day, taken in one dose at breakfast. This can vary from 1 to 3 tablets daily, taken in one or several daily doses.
1. In what conditions can I use Arcalion?
Arcalion can be used to treat any type of asthenia. One can combine it with antibiotics in patients with infectious disease to speed up the recovery. In chronic disease such as diabetes, hypertension and heart disease, Arcalion improves the underlying asthenia and improves the quality of life.
Apart from this, Arcalion can be safely given in students to improve their concentration and memory.
2. What is the recommended duration of therapy with Arcalion?
The duration of therapy varies with the clinical indication. Ideally, a minimum of 2 weeks of therapy is essential at a dose of just 2 tablets daily.
3. By when can I see the effects with Arcalion?
Arcalion has been shown to improve asthenia from the 4th day of starting the treatment.